相关实验视频
Updated: Jun 12, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
在烧伤ICU患者中,针对肺炎的甲基西林耐药黄金葡萄球菌鼻拭子的预测值
Zachary Carlson1, Robyn Stoianovici1, Sierra Young1
1Department of Clinical Pharmacy, UC Davis Medical Center, Sacramento, CA, USA.
在怀疑肺炎的烧伤ICU患者中,阴性MRSA鼻子拭子具有高度的特异性和准确性,可以排除感染. 这可以帮助降低抗生素的升级,但重复的扫描可能是有益的.
科学领域:
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
- 烧伤手术 烧伤手术
背景情况:
- 肺炎是烧伤重症监护室 (ICU) 患者常见的并发症.
- 准确的早期诊断对于适当的抗生素选择和缓和至关重要.
研究的目的:
- 为了评估甲素耐药黄金葡萄球菌 (MRSA) 的诊断性能,在烧伤ICU患者中为肺炎进行鼻腔抹拭.
- 为了确定MRSA鼻的灵敏度,特异性,正预测值 (PPV) 和负预测值 (NPV).
主要方法:
- 成年烧伤ICU患者 (2016-2021) 的回顾性队列研究.
- 纳入标准:烧伤,肺炎诊断,入院时的MRSA鼻子抹布,以及超过5天抗生素的呼吸道培养物.
- 与抗生素启动相比,抽样时间的分析.
主要成果:
- 在136名患者中有267例肺炎病例.
- 总的来说,MRSA鼻的敏感性:39%,特异性:98.7%,PPV:84.2%,NPV:89.9%.
- 抗生素抽样<7天:特异性为98.6%,NPV为98.6%. 抽样>=7天:特异性为98.7%,净净值为86.4%.
结论:
- MRSA鼻的高特异性和NPV表明,在怀疑肺炎的稳定烧伤患者中,抗MRSA抗生素的降级实用性,特别是当从抗生素开始后获得<7天时.
- 随着后期抽样的NPV下降,表明定期重复抽样的潜在好处.
- 阴性MRSA鼻可以指导这种脆弱患者群体的抗生素管理.
更多相关视频
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: